CIDRAP newsletters options
France has now reported 63 local chikungunya cases from 16 different administrative units.
Vaccination of all US adults may be attractive not only for its expected health gains but also for its economic benefits, the authors say.
Cases and deaths have already outpaced totals for 2024, and new outbreaks have emerged in Gambia, Cameroon, and Mozambique.
The WHO guidance aims to spur development of in vitro diagnostic tests that can quickly and accurately identify serious bacterial infections in infants and newborns.
Among patients hospitalized with community-acquired pneumonia in Georgia and Tennessee, 14% had pneumococcal pneumonia.
Anyone in Central Harlem experiencing flu-like symptoms should seek medical care.
For infants born from October to February, maternal vaccination was cost-effective, but nirsevimab was cost-effective only in those born in October and November.
Officials estimated that 228 fewer babies younger than 3 months older were hospitalized for serious RSV infection during the peak of the season, a number they hope will increase as more women are vaccinated.
The odds of a respiratory tract infection and any infection were lower in the SARS-CoV-2 group.
Experts say the move risks national security by leaving the US vulnerable to the next pandemic virus.
The recent cases don't have epi connections, but fruit bats known to harbor the virus were seen in the outbreak area.
Three more outbreaks were reported, bringing the year's total to 32, double the number reported for all of 2024.
Clarametyx Biosciences announced that CMTX-101, a monoclonal antibody designed to collapse bacterial biofilms, will receive priority review and other development incentives from the FDA.
Seven of the 15 cases from Cambodia this year have been fatal, resulting in a case-fatality rate of 46.6%.
Treatment with oseltamivir was associated with an approximately 50% reduction in the incidence of serious neuropsychiatric events.
Only a small fraction examine whether these devices or systems reduce human infections or identify potential harmful emissions.
Seven people have been hospitalized, and severe complications have been reported for at least two cases.
Notably, the dual therapy group had significantly lower 28-day mortality compared to their monotherapy peers and was associated with a shorter viral shedding time.
Among hospitalized pneumonia patients, screening for MRSA colonization with a nasal swab-based rapid PCR test cut duration of anti-MRSA antibiotics by 2 days.
The CDC's latest chikungunya travel advisory is for a hot spot in China's Guangdong province.
